Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Stadtmauer
Real World Outcomes of Obinutuzumab Monotherapy in Patients With Chronic Lymphocytic Leukemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
Obinutuzumab in Chronic Lymphocytic Leukemia: Design, Development and Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Comorbidities Predict Inferior Outcomes in Chronic Lymphocytic Leukemia Treated With Ibrutinib
Cancer
Cancer Research
Oncology
Acalabrutinib With Obinutuzumab in Treatment-Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia: 3-Year Follow-Up
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide
Clinical Journal of Oncology Nursing
Oncology
Real-World Testing and Treatment Patterns in Chronic Lymphocytic Leukemia: A SEER Patterns of Care Analysis
Cancer
Cancer Research
Oncology
Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia
Pathologia
Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology